Diagnostic Value of Combined Parameters for α-Thalassemia-1 Screening in Pregnant Women

Orathai Tangvarasittichai; Rattima Jeenapongsa; Chanthonrat Sitthiworanan; Torpong Sanguansermsri

Authors

Orathai Tangvarasittichai Department of Medical Technology, Faculty of Allied Health Sciences, Naresuan University,Phitsanulok 65000, Thailand.
Rattima Jeenapongsa Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University,Phitsanulok 65000, Thailand.
Chanthonrat Sitthiworanan Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University,Phitsanulok 65000, Thailand.
Torpong Sanguansermsri Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai 50000,Thailand.

Keywords:

α-thalassemia-1 screening, combined parameters, specificity

Abstract

Hb Bart’s hydrops fetalis, the most severe case α-thalassemia, can be prevented with an early effective diagnosis of α-thalassemia-1 carrier pregnant women. Current commonly used diagnostic parameter is MCV or OFT. However both tests are not specific enough. Therefore, more samples are required further tests. This study aimed to investigate a parameter or combined parameters that provide(s) higher specificity and sensitivity in differential diagnosis between carriers and non-carriers of α-thalassemia-1. Blood samples were collected from 1,000 pregnant women attending an antenatal clinic, Buddhachinaraj Hospital, Phitsanulok. The EDTA anticoagulated blood was subjected to determination of RBC count, RBC indices (Hb, Hct, MCH, MCHC, MCV and RDW) by an automated blood cell analyzer, OFT and DNA extraction for PCR-based assay. Data were analyzed by ROC curves and discriminant analysis and then compared with Student’s t-test. This study showed that combined parameters revealed more effective diagnosis of α-thalassemia-1 than a single parameter. Considering 100% sensitivity, the most effective combination indicator was MCH/OFT/RDW (92.4% specificity), followed by MCH/OFT/MCV (91.9% specificity), MCH/OFT (91.7% specificity), MCH/RDW/MCV (90.0% specificity), MCH/ RDW (89.6% specificity) and MCH/MCV (88.5% specificity). MCH, MCV and OFT used as a single parameter exhibited % specificity of 87.3, 82.4 and 81.7%, respectively. The cut-off points of these parameters were as followed: MCH (≤ 25 pg), MCV (≤ 75 fL), RDW (≥ 14.5%) and OFT (≤ 55%). The results suggested that the parameter combinations provide better predictive values of a positive test for α-thalassemia-1 carriers with no false negative. The best combined parameter was MCH/OFT/RDW.

References

Clarke, G. M., & Higgins, T. N. (2000). Laboratory investigation of hemoglo binopathies and thalassemia: review and update. Clinical Chemistry, 46, 1284-1290.

Greenberg, P. L., Gordeul, V., Issaragrisil, S., Siritanaratkul, N., Fucharoen, S., & Ribeiro, R. C. (2001). Major hemotologic disease in the developing world - New aspects of diagnosis and management of thalassemia, malarial anemia and acute leukemia. Hematology, 479-498.

Sanguansermsri, T., Phumyu, N., Chomchuen, S., & Steger, H.F. (1999). Screening for alpha-thalassemia-1 heterozygotes in expecting couples by the combination of a simple erythrocyte osmotic fragility test and a PCR based method. Community Genetic, 2, 26-29.

Walsh, P. S., Metzger, D. A., & Higuchi, R. (1991). Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques, 10, 506-513.

Weatherall, D. J. (1998). Thalassemia in the next millenium: Keynote address.

Annals of the New York Academiy of Sciences, 850, 1-9.